Drug Repurposing Flubendazole to Suppress Tumorigenicity via PCSK9-dependent Inhibition and Potentiate Lenvatinib Therapy for Hepatocellular Carcinoma

Wenjiao Jin, Junming Yu, Yang Su, Hechun Lin, Tengfei Liu, Jing Chen, Chao Ge, Fangyu Zhao, Qin Geng, Lin Mao,

International Journal of Biological Sciences · 2023 · 20 citations · 54 references

DOIFull text

Open access

Concepts

Abstract

. These findings reveal the therapeutic potential of flubendazole against HCC and provide clues on new repurposed drugs and targets for cancer treatment.

References

54